Composition

Each vial of 5 mL of solution contains:
Levetiracetam 500 mg
Excipients q.s.

Indications

LEOVAL is indicated as monotherapy in the treatment of partial onset seizures, with or without secondary generalization in adults and adolescents over 16 years of age with a new diagnosis of epilepsy.

LEOVAL is indicated as concomitant therapy:
- In the treatment of partial onset seizures with or without secondary generalization in adults, adolescents and children over 4 years of age with epilepsy.
- In the treatment of myoclonic seizures in adults and adolescents over 12 years of age with Juvenile Myoclonic Epilepsy.
- In the treatment of primary generalized tonic-clonic seizures in adults and adolescents over 12 years of age with Generalized Idiopathic Epilepsy.

Levetiracetam concentrate is an alternative for patients in whom oral administration is temporarily not feasible.